News

For the first time, MRI has been used to show how the heart uses oxygen during normal health, and in those with heart disease.

What if wearing a blood pressure cuff could help prevent stroke? In a new study, people who restricted their blood flow by wearing inflated blood pressure cuffs on an arm and leg showed signs of more controlled blood flow to their brain, a process that could be protective if blood flow is more severely restricted in the event of a stroke.

Scientists have deciphered for the first time how a virus genome is condensed inside the capsid of a virus.

Tracking the percentage of primed neutrophils in the blood – cells that are in a state of activation – could provide key information about immune health relevant for diagnosing inflammatory diseases such as cancer and osteoarthritis.

Although the importance of machine learning methods in genome research has grown steadily in recent years, researchers have often had to resort to using obsolete software. Scientists in clinical research often did not have access to the most recent models. This will change with the new free open access repository: Kipoi.

In a ten-year study of more than 100,000 women, researchers examined extensive details of women’s night shift work, discovering that those who worked night shifts were no more likely to develop breast cancer than those who had not.

To thwart sophisticated methods of altering photos and video, researchers at the NYU Tandon School of Engineering have demonstrated an experimental technique to authenticate images throughout the entire pipeline, from acquisition to delivery, using artificial intelligence (AI).

Through cost-saving practices for coffee, rice, corn and livestock production, Vietnam can take steps to meet Paris Agreement commitments and save the country an estimated $2.3 billion by 2030.

A synthetic, non-intoxicating analogue of cannabidiol (CBD) has been shown to be effective at treating seizures in rats, according to research by chemists at the University of California, Davis.

Nearly all humans silently harbor polyomavirus, a tiny DNA virus, but when transplant recipients receive drugs to suppress their immune system to prevent graft rejection, the virus can reactivate and damage the kidney. A new approach to targeting infected cells may help reduce viral load in transplant patients.